Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China
Mismatch between circulating influenza B viruses and vaccine strains occurs frequently. In a randomized, double-blind, controlled phase III clinical study, healthy children aged 6–35 months were randomized into three groups at a ratio of 2:1:1, received two doses of quadrivalent influenza vaccines (...
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Taylor & Francis Group
2020-07-01
|
| Serie: | Human Vaccines & Immunotherapeutics |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.1080/21645515.2020.1721994 |